Advanced Enzyme Technologies Approves Share Buyback, Acquires Remaining Stake in JCB and Funds ANPL
Advanced Enzyme Technologies Limited announced several significant corporate actions following its Board Meeting held on August 08, 2026. The company approved the acquisition of the remaining stake in JC Biotech Private Limited (JCB), a step set to make JCB a Wholly Owned Subsidiary, while also sanctioning a large-scale share buyback and planned funding for Advanced Nutrazyme Private Limited (ANPL).The Board approved the Buyback of fully paid-up equity shares at a price not exceeding ? 500 per equity share. The maximum size set for this transaction is t 697,000,000, which could account for up to 1,394,000 Equity Shares, representing...